Trials / Recruiting
RecruitingNCT06889844
Observational Cross-reactivity Study for Colorectal Cancer Diagnosis
Observational Cross-reactivity Study to Evaluate the Specificity of a Blood Test for Colorectal Cancer Diagnosis Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- ADVANCED MARKER DISCOVERY S.L. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this observational study is to evaluate the false positive rate of the blood test based on molecular biomarkers and risk factors. A total of 250 patients diagnosed with various cancers and gastrointestinal diseases will be enrolled. The main question to be answered is Does the blood test have a low false positive rate in the main study population? Participants will donate a blood sample as part of their regular medical care for cancer diagnosis and give the consent to know their clinical risk factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | blood sampling | Patients will donate a blood sample for molecular analysis of molecular biomarkers in plasma, which being the only procedure in the study. |
Timeline
- Start date
- 2023-04-17
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2025-03-21
- Last updated
- 2025-10-01
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT06889844. Inclusion in this directory is not an endorsement.